$6.92
-0.02-0.29%
At close: -
$6.94
0.020.29%
After Hours: 8:10 AM EDT
Comments
Loading...
Atara Biotherapeutics Earnings Estimates, EPS & Revenue | NASDAQ:ATRA | Benzinga
Atara Biotherapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$1.460
Quarterly Revenue Estimate
$46.90M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$128.94M
Analyze the earnings history of Atara Biotherapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ATRA | Atara Biotherapeutics | -$5.75 | $1.46 | — | — | $27.36M | $46.90M | — | — | 05/08/2025 | Get Alert |
| ATRA | Atara Biotherapeutics | -$14.00 | -$2.48 | -$1.19 | 52.02% | $4.25M | $24.75M | $32.75M | 32.34% | 03/07/2025 | Get Alert |
| ATRA | Atara Biotherapeutics | -$16.50 | -$1.93 | -$2.93 | -51.81% | $2.14M | $35.17M | $40.19M | 14.27% | 11/12/2024 | Get Alert |
| ATRA | Atara Biotherapeutics | -$17.00 | -$1.56 | -$3.10 | -98.72% | $957.00K | $39.99M | $28.64M | -28.38% | 08/12/2024 | Get Alert |
| ATRA | Atara Biotherapeutics | -$18.00 | -$6.50 | -$5.75 | 11.54% | $1.23M | $24.69M | $27.36M | 10.80% | 05/09/2024 | Get Alert |
| ATRA | Atara Biotherapeutics | -$18.00 | -$12.00 | -$14.00 | -16.67% | $221.00K | $11.55M | $4.25M | -63.19% | 03/28/2024 | Get Alert |
| ATRA | Atara Biotherapeutics | -$20.50 | -$16.50 | -$16.50 | 0.00% | $4.46M | $4.76M | $2.14M | -55.08% | 11/01/2023 | Get Alert |
| ATRA | Atara Biotherapeutics | -$7.75 | -$16.75 | -$17.00 | -1.49% | $51.58M | $3.77M | $957.00K | -74.62% | 08/08/2023 | Get Alert |
| ATRA | Atara Biotherapeutics | -$21.75 | -$9.75 | -$18.00 | -84.62% | $7.31M | $30.68M | $1.23M | -96.00% | 05/08/2023 | Get Alert |
| ATRA | Atara Biotherapeutics | -$24.00 | -$12.75 | -$18.00 | -41.18% | $7.55M | $39.67M | $221.00K | -99.44% | 02/08/2023 | Get Alert |
| ATRA | Atara Biotherapeutics | -$22.50 | -$19.50 | -$20.50 | -5.13% | $5.37M | $5.27M | $4.46M | -15.39% | 11/08/2022 | Get Alert |
| ATRA | Atara Biotherapeutics | -$22.75 | -$23.25 | -$7.75 | 66.67% | $3.87M | $6.84M | $51.58M | 654.08% | 08/08/2022 | Get Alert |
| ATRA | Atara Biotherapeutics | -$21.50 | -$24.50 | -$21.75 | 11.22% | $3.55M | $4.91M | $7.31M | 48.96% | 05/05/2022 | Get Alert |
| ATRA | Atara Biotherapeutics | -$23.75 | -$17.25 | -$24.00 | -39.13% | $0.00 | $35.14M | $7.55M | -78.52% | 02/28/2022 | Get Alert |
| ATRA | Atara Biotherapeutics | -$23.00 | -$23.50 | -$22.50 | 4.26% | $0.00 | $3.92M | $5.37M | 36.99% | 11/04/2021 | Get Alert |
| ATRA | Atara Biotherapeutics | -$28.50 | -$22.25 | -$22.75 | -2.25% | $0.00 | $3.84M | $3.87M | 0.78% | 08/09/2021 | Get Alert |
| ATRA | Atara Biotherapeutics | -$30.00 | -$23.00 | -$21.50 | 6.52% | $0.00 | $1.60M | $3.55M | 122.00% | 05/04/2021 | Get Alert |
| ATRA | Atara Biotherapeutics | -$34.00 | -$18.50 | -$23.75 | -28.38% | $0.00 | $13.33M | $0.00 | -100.00% | 03/01/2021 | Get Alert |
| ATRA | Atara Biotherapeutics | -$32.75 | -$27.25 | -$23.00 | 15.60% | $0.00 | — | $0.00 | — | 11/09/2020 | Get Alert |
| ATRA | Atara Biotherapeutics | -$40.00 | -$29.50 | -$28.50 | 3.39% | $0.00 | — | $0.00 | — | 08/05/2020 | Get Alert |
| ATRA | Atara Biotherapeutics | -$36.00 | -$35.25 | -$30.00 | 14.89% | $0.00 | — | $0.00 | — | 05/06/2020 | Get Alert |
Atara Biotherapeutics (ATRA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-07 | $-1.19 | $-2.48 | 52.0 % |
| Q3 | 2024-11-12 | $-2.93 | $-1.93 | -51.8 % |
| Q2 | 2024-08-12 | $-3.10 | $-1.56 | -98.7 % |
| Q1 | 2024-05-09 | $-5.75 | $-6.50 | 11.5 % |
Atara Biotherapeutics (ATRA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-07 | $32.75M | $24.75M | 32.3 % |
| Q3 | 2024-11-12 | $40.19M | $35.17M | 14.3 % |
| Q2 | 2024-08-12 | $28.64M | $39.99M | -28.4 % |
| Q1 | 2024-05-09 | $27.36M | $24.69M | 10.8 % |
FAQ
When is Atara Biotherapeutics (NASDAQ:ATRA) reporting earnings?
Atara Biotherapeutics (ATRA) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 7, 2025 for Q4.
What were the latest earnings per share (EPS) for Atara Biotherapeutics (NASDAQ:ATRA)?
The Actual EPS was $-1.19, which beat the estimate of $-2.48.
What were Atara Biotherapeutics’s (NASDAQ:ATRA) revenues?
The Actual Revenue was $32.8M, which beat the estimate of $24.8M.
Browse earnings estimates, EPS, and revenue on all stocks.